Exodus Point Capital Management, LP Spring Works Therapeutics, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 114,300 shares of SWTX stock, worth $4.79 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
114,300
Previous 142,355
19.71%
Holding current value
$4.79 Million
Previous $5.36 Million
31.72%
% of portfolio
0.02%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$281 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$235 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$161 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$147 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$143 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.61B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...